Literature DB >> 2548119

Treatment of infantile spasms with high-dose ACTH: efficacy and plasma levels of ACTH and cortisol.

O C Snead1, J W Benton, L C Hosey, J W Swann, D Spink, D Martin, R Rej.   

Abstract

Fifteen children with infantile spasms and a hypsarrhythmic EEG defined by EEG-videotelemetry monitoring received a regimen of high-dose (150 IU/m2/d) ACTH for their seizures. We carried out an endocrinologic evaluation before and after initiation of the ACTH and conducted a time course study of plasma ACTH and cortisol levels after ACTH dosing. Spasms were controlled and the EEG normalized in 14 of the 15 children. Prior to starting ACTH therapy all the patients had normal prolactin, insulin, cortisol, and ACTH levels in plasma and normal thyroid function. Although the pattern of rise of ACTH levels in plasma after ACTH dosing was similar in all the children, there was great individual variation in the absolute concentrations. However, both the pattern of rise and absolute level of cortisol in plasma after ACTH was highly predictable in all patients. Plasma cortisol rose rapidly within 1 hour of ACTH administration and continued a slower rise for 12 to 24 hours after the ACTH dose. High-dose ACTH therapy seems quite effective in infantile spasms, perhaps because of a sustained high level of plasma cortisol. This sustained plateau of cortisol may be more effective in controlling infantile spasms than the pulse effect expected with oral steroids or lower doses of ACTH.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548119     DOI: 10.1212/wnl.39.8.1027

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  Treatment of infantile spasms: the ideal and the mundane.

Authors:  Tallie Z Baram
Journal:  Epilepsia       Date:  2003-08       Impact factor: 5.864

Review 2.  A risk-benefit assessment of treatments for infantile spasms.

Authors:  R Nabbout
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  Treatment of infantile spasms with very high dose prednisolone before high dose adrenocorticotropic hormone.

Authors:  Shaun A Hussain; Shlomo Shinnar; Grace Kwong; Jason T Lerner; Joyce H Matsumoto; Joyce Y Wu; W Donald Shields; Raman Sankar
Journal:  Epilepsia       Date:  2013-11-08       Impact factor: 5.864

4.  Corticotropin (ACTH) acts directly on amygdala neurons to down-regulate corticotropin-releasing hormone gene expression.

Authors:  K L Brunson; N Khan; M Eghbal-Ahmadi; T Z Baram
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

Review 5.  Corticosteroids in the management of the paediatric epilepsies.

Authors:  R Gupta; R Appleton
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

Review 6.  Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain.

Authors:  T Z Baram; C G Hatalski
Journal:  Trends Neurosci       Date:  1998-11       Impact factor: 13.837

7.  CCR4 agonists CCL22 and CCL17 are elevated in pediatric OMS sera: rapid and selective down-regulation of CCL22 by ACTH or corticosteroids.

Authors:  Michael R Pranzatelli; Elizabeth D Tate; Nathan R McGee; Jerry A Colliver; Richard M Ransohoff
Journal:  J Clin Immunol       Date:  2013-01-23       Impact factor: 8.317

Review 8.  Pathophysiology of massive infantile spasms: perspective on the putative role of the brain adrenal axis.

Authors:  T Z Baram
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

9.  Improving Management of Infantile Spasms by Adopting Implementation Science.

Authors:  Debopam Samanta
Journal:  Neuropediatrics       Date:  2020-10-13       Impact factor: 1.947

10.  Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.

Authors:  Shahnaz Ibrahim; Shamshad Gulab; Sidra Ishaque; Taimur Saleem
Journal:  BMC Pediatr       Date:  2010-01-15       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.